Correlation Between Janux Therapeutics and Ideaya Biosciences
Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Ideaya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Ideaya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Janux Therapeutics and Ideaya Biosciences, you can compare the effects of market volatilities on Janux Therapeutics and Ideaya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Ideaya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Ideaya Biosciences.
Diversification Opportunities for Janux Therapeutics and Ideaya Biosciences
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Janux and Ideaya is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Ideaya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ideaya Biosciences and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Ideaya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ideaya Biosciences has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Ideaya Biosciences go up and down completely randomly.
Pair Corralation between Janux Therapeutics and Ideaya Biosciences
Given the investment horizon of 90 days Janux Therapeutics is expected to generate 2.71 times more return on investment than Ideaya Biosciences. However, Janux Therapeutics is 2.71 times more volatile than Ideaya Biosciences. It trades about -0.04 of its potential returns per unit of risk. Ideaya Biosciences is currently generating about -0.15 per unit of risk. If you would invest 4,521 in Janux Therapeutics on November 29, 2024 and sell it today you would lose (1,261) from holding Janux Therapeutics or give up 27.89% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Janux Therapeutics vs. Ideaya Biosciences
Performance |
Timeline |
Janux Therapeutics |
Ideaya Biosciences |
Janux Therapeutics and Ideaya Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Janux Therapeutics and Ideaya Biosciences
The main advantage of trading using opposite Janux Therapeutics and Ideaya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Ideaya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ideaya Biosciences will offset losses from the drop in Ideaya Biosciences' long position.Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute | Janux Therapeutics vs. Keros Therapeutics |
Ideaya Biosciences vs. AnaptysBio | Ideaya Biosciences vs. MeiraGTx Holdings PLC | Ideaya Biosciences vs. Keros Therapeutics | Ideaya Biosciences vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |